Portable
Our analyzer is compact and lightweight, enabling easy transport to various settings.
Our mission is to empower healthcare providers with cutting-edge technology to enhance patient care and drive positive change.
O-in is an innovative biotechnology product from Taiwan, designed to make biomedical testing more affordable and accessible.
With advanced technology and user-centric design, O-in delivers reliable diagnostic results, empowering healthcare professionals and patients with critical insights to guide better treatment decisions.
By enabling precise and personalized healthcare solutions, O-in is setting a new standard in diagnostics, meeting the unique needs of individuals and advancing the field of precision medicine.
Region | Cases | Deaths |
---|---|---|
Europe | 671,000 | 33,000 |
North America | 2,000,000 | 23,000 |
China | N/A | 80,000 |
Taiwan | 140,000 | 3,000 |
India | N/A | N/A |
These statistics highlight the global scale of the AMR crisis. The threat is real and immediate, and it’s crucial to develop innovative solutions to combat it.
Antimicrobial resistance (AMR) is a global health crisis with substantial economic and societal consequences.
The rising prevalence of AMR infections leads to longer hospital stays, increased healthcare costs, and higher mortality rates.
Annually worldwide due to AMR.
Annually spent to treat AMR.
Our analyzer is compact and lightweight, enabling easy transport to various settings.
Our system integrates all necessary components for molecular diagnostic testing.
Our technology eliminates the need for extensive sample preparation, streamlining the process.
Our analyzer delivers precise results, comparable to larger, more complex laboratory systems.
The cartridge is easily inserted into the portable analyzer. The cartridge contains the microfluidic chip and reagents for analysis.
The user collects a sample, such as blood or urine, and inserts it into the cartridge.
The analyzer automatically performs the assay, detecting the presence or absence of antibiotic resistance genes.
Results are displayed on the analyzer’s screen in real-time, providing immediate insights for informed treatment decisions.
The data can be easily integrated with electronic health records (EHRs) or other systems for further analysis and tracking.